SA
Log In
ZVRA
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
8 analysts·Limited coverage
75
Score
8 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
8100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$23.00
+128.9%
Consensus
$24.00
+138.8%
Bull
$26.00
+158.7%
12-Month Target Range8 analysts
$23.00$24.00$26.00
Current $10.05Consensus
Current Price
$10.05
Upside to Consensus
$13.95

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+53.42%
EPS+205.48%
FY2028
Rev+39.64%
EPS+68.93%
FY2029
Rev+17.74%
EPS+21.22%

Earnings Surprises

Recent Analyst Actions

Mar 10, 2026Guggenheim
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $23 at Guggenheim
Target:$23.00
+108.5%from $11.03
Dec 30, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
Target:$26.00
+194.8%from $8.82
Nov 6, 2025Cantor Fitzgerald
Zevra Therapeutics price target lowered to $24 from $29 at Cantor Fitzgerald
Target:$24.00
+158.5%from $9.29
Nov 6, 2025Canaccord Genuity
Zevra Therapeutics price target lowered to $24 from $25 at Canaccord
Target:$24.00
+168.2%from $8.95
Mar 13, 2025Guggenheim
Zevra Therapeutics price target raised to $22 from $20 at Guggenheim
Target:$22.00
+177.1%from $7.94
Mar 12, 2025JMP Securities
Zevra Therapeutics price target raised to $18 from $17 at Citizens JMP
Target:$18.00
+127.3%from $7.92
Feb 4, 2025Guggenheim
Zevra Therapeutics price target raised to $21 from $20 at Guggenheim
Target:$21.00
+158.3%from $8.13
Sep 24, 2024Roth Capital
Zevra Therapeutics price target raised to $21 from $19 at Roth MKM
Target:$21.00
+177.0%from $7.58
Sep 24, 2024Maxim Group
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Maxim Group
Target:$25.00
+229.8%from $7.58
Sep 24, 2024JMP Securities
JMP Securities Starts Zevra Therapeutics, Inc. (ZVRA) at Market Outperform
Target:$17.00
+124.3%from $7.58
Sep 23, 2024H.C. Wainwright
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $20 at H.C. Wainwright
Target:$20.00
+152.5%from $7.92
Sep 18, 2024Canaccord Genuity
Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $22 at Canaccord Genuity
Target:$22.00
+192.2%from $7.53

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance